1. Home
  2. AARD vs STEX Comparison

AARD vs STEX Comparison

Compare AARD & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$3.81

Market Cap

281.1M

Sector

Health Care

ML Signal

HOLD

STEX

Streamex Corp.

N/A

Current Price

$1.01

Market Cap

297.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AARD
STEX
Founded
2017
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
297.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AARD
STEX
Price
$3.81
$1.01
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$19.63
$12.00
AVG Volume (30 Days)
487.6K
1.8M
Earning Date
03-23-2026
05-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2,107.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.35
$1.04
52 Week High
$17.94
$7.44

Technical Indicators

Market Signals
Indicator
AARD
STEX
Relative Strength Index (RSI) 22.54 24.87
Support Level N/A N/A
Resistance Level $6.19 $3.68
Average True Range (ATR) 0.38 0.20
MACD 0.14 -0.04
Stochastic Oscillator 17.29 3.50

Price Performance

Historical Comparison
AARD
STEX

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. It is focused on the tokenization and digitalization of real-world assets. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

Share on Social Networks: